A vaccine for childhood respiratory viral infections is a step closer after an Mater Research Institute—UQ immunopathology specialist was awarded a prestigious Children’s Hospital Foundation grant.

Professor Maher Gandhi will be appointed as Chief Executive Officer of Mater Research and Director of MRI-UQ, effective May 1 2019.

Dr Seth Cheetham has been awarded three grants to fund research projects addressing the role of genomic plasticity in cancer treatment.

Prof Peter Nestor was recently appointed Conjoint Professor of Neuroscience between The University of Queensland and Mater and has started his appointment by establishing a memory clinic at Mater.

Newly appointed Director of Operations at Mater Research Aimee Catalan has recently accepted the title of Adjunct Associate Professor at MRI–UQ.

A landmark Queensland study will investigate whether genetics hold the key to faster diagnosis and treatment of sepsis.

A Mater Researcher has found that hormones, in conjunction with immune markers, may be valuable in determining those who will not respond to treatment for Tuberculosis (TB).

Queensland researchers have discovered a new way to target a rare form of breast cancer, giving hope for improved treatment options.

A Mater Research trial is underway to test a new treatment for Ross River fever.

Research describes novel hand bone formation ‘roadmap’ that reveals new treatment considerations for some skeletal dysplasias.

A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency.

Australia’s only research Centre dedicated to the business and economics of health aims to address fundamental issues in health systems in Australia and globally.